Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward Reports First Quarter 2026 Financial Results
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
Lifeward (NASDAQ:LFWD) Trading Up 2.5% – Should You Buy?
Lifeward Successfully Closes on Strategic Partnership with Oramed
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
Lifeward Announces Reverse Share Split
Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
Oramed and Lifeward Announce Strategic Transaction
Lifeward Appoints Bob Marshall as Chairman of the Board
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
Lifeward Ltd. (LFWD) Q3 2025 Earnings Call Transcript
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
Lifeward to Report Third Quarter Financial Results on November 14, 2025
Lifeward Achieves European Approval for Latest ReWalk Exoskeleton
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript
Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
Lifeward to Report Second Quarter Financial Results on August 14, 2025
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
Lifeward Announces Closing of $2.6 Million Public Offering
Lifeward Announces Pricing of $2.6 Million Public Offering
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
Lifeward Names Mark Grant as New CEO
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript
Lifeward Ltd. Reports First Quarter 2025 Financial Results
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7